Prior treatment of cells with 10 μM of SPHK-I2 for 24 h resulted in a significant reduction in serum-induced proliferation of mesothelioma cells (by about 40–50%); however, the control cell line Met5A was insensitive to the inhibitor at the concentration tested (Fig. 3B). This evidence concerns the gene SPHK1 and mesothelioma.